2005
HIV Drug Resistance and HIV Transmission Risk Behaviors Among Active Injection Drug Users
Kozal MJ, Amico KR, Chiarella J, Cornman D, Fisher W, Fisher J, Friedland G. HIV Drug Resistance and HIV Transmission Risk Behaviors Among Active Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2005, 40: 106-109. PMID: 16123691, DOI: 10.1097/01.qai.0000159666.95455.d2.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug-resistant HIVHIV drug resistanceResistant HIVDrug usersRisk behaviorsClinical careActive injection drug usersDrug resistanceHIV transmission risk behaviorsTransmission risk behaviorsInjection risk behaviorsRetrospective studyInjection drugsHIVPrevious monthCareSubstantial numberMultiple partnersDrugsSmall proportionPatientsProportionNeedleMonths
1999
Stavudine Resistance: An Update on Susceptibility following Prolonged Therapy
Lin P, González C, Griffith B, Friedland G, Calvez V, Ferchal F, Schinazi R, Shepp D, Ashraf A, Wainberg M, Soriano V, Mellors J, Colonno R. Stavudine Resistance: An Update on Susceptibility following Prolonged Therapy. Antiviral Therapy 1999, 4: 21-28. PMID: 10682125, DOI: 10.1177/135965359900400103.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAnti-HIV AgentsDrug ResistanceHIV-1HumansPhenotypeRNA-Directed DNA PolymeraseStavudineConceptsPost-treatment isolatesStavudine resistanceStavudine therapyFirst-line combination therapyAmino acid changesUse of stavudineMonths of treatmentClinical HIV-1HIV-1 strainsNucleoside analoguesAcid changesProlonged therapyHIV patientsConsistent amino acid changesCombination therapyMulti-resistant phenotypeHIV-1Lower incidenceReverse transcriptase geneClinical isolatesTherapyDrug sensitivityPatientsTranscriptase geneCurrent report